Company news
Impact Biomedical, Inc. (AMEX:IBO) news
Impact Biomedical, Inc. news releases on 6ix. Latest, Sep 16, 2026: Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection…
Press releases & updates
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
September 16, 2026
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd.)
September 14, 2026
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
September 11, 2026
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
April 3, 2026
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
August 18, 2025
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
June 23, 2025
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”
February 26, 2025
Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue
September 26, 2024